Jingyue Announces Submission of 115 Q2 Consolidated Financial Report to Board of Directors
Jingyue has submitted its consolidated financial report for the second quarter of 2026 to the Board … · 2026-08-12
Jingyue has submitted its consolidated financial report for the second quarter of 2026 to the Board … · 2026-08-12
Ching Yueh announced that the board meeting to review the Q2 2026 financial report will be held on A… · 2026-08-04
Ching Yue Biotech announces the commitments made during its application for stock listing transfer f… · 2026-07-06
Ching Yue announces the expiration of the term for its fifth Compensation Committee members. Outgoin… · 2026-06-29
Jingyue announced the commitments made during its IPO listing and their execution status as of the e… · 2026-04-07
Jingyue announced the commitments made during its IPO listing and their execution status as of the e… · 2026-04-07
Genmont Biotechnology announced its February 2026 monthly revenue was NT$0.16 billion, a year-on-yea… · 2026-02-01
GenMont Biotech (code: 3164), operating in the biotechnology and medical industry, announced its rev… · 2026-05-01
GenMont Biotech Inc. held its Annual General Meeting on June 8, 2026, approving the profit distribut… · 2026-06-08
GenMont Biotech announced the election of the chairman. Chen Gen-Te was re-elected as chairman, effe… · 2026-06-08
GenMont Biotech announced the list of directors elected, with changes reaching one-third due to term… · 2026-06-08
GenMont Biotech's shareholders' meeting resolved to permit directors to engage in competitive busine… · 2026-06-08
GenMont Biotech announced the change of members of the third audit committee due to term expiration.… · 2026-06-08
Jingyue announced the commitments made during its IPO listing and their execution status as of the e… · 2026-04-07
GenMont (3164), in the biotechnology and medical care industry, announced its monthly revenue for Ma… · 2026-03-01
Jingyue reported April 2026 revenue of 37.785 million yuan, a 5.4% decrease year-over-year. This dec… · 2026-04-01
Jingyue announced and submitted its consolidated financial report for Q1 2026 to the board of direct… · 2026-05-06
Kingcar announced that its board meeting to approve the 115 First Quarter Financial Report is schedu… · 2026-04-28
GenMont (3164), in the biotechnology and medical care industry, announced its monthly revenue for Ma… · 2026-03-01
Genmont Biotechnology announced its February 2026 monthly revenue was NT$0.16 billion, a year-on-yea… · 2026-02-01
Kingcar announced that its board meeting to approve the 115 First Quarter Financial Report is schedu… · 2026-04-28
Jingyue reported April 2026 revenue of 37.785 million yuan, a 5.4% decrease year-over-year. This dec… · 2026-04-01
Jingyue announced and submitted its consolidated financial report for Q1 2026 to the board of direct… · 2026-05-06